IBDEI0OW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12200,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,12201,0)
 ;;=V87.39^^66^737^1
 ;;^UTILITY(U,$J,358.3,12201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12201,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,12201,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,12201,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,12202,0)
 ;;=310.0^^66^738^2
 ;;^UTILITY(U,$J,358.3,12202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12202,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,12202,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,12202,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,12203,0)
 ;;=310.1^^66^738^3
 ;;^UTILITY(U,$J,358.3,12203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12203,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,12203,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,12203,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,12204,0)
 ;;=310.2^^66^738^4
 ;;^UTILITY(U,$J,358.3,12204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12204,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,12204,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,12204,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,12205,0)
 ;;=310.81^^66^738^5
 ;;^UTILITY(U,$J,358.3,12205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12205,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,12205,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,12205,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,12206,0)
 ;;=310.89^^66^738^1
 ;;^UTILITY(U,$J,358.3,12206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12206,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,12206,1,5,0)
 ;;=5^Brain Damage D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,12206,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,12207,0)
 ;;=97762^^67^739^1^^^^1
 ;;^UTILITY(U,$J,358.3,12207,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12207,1,2,0)
 ;;=2^C/O For Orthotic/Prosth Use
 ;;^UTILITY(U,$J,358.3,12207,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,12208,0)
 ;;=97760^^67^739^2^^^^1
 ;;^UTILITY(U,$J,358.3,12208,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12208,1,2,0)
 ;;=2^Orthotic Mgmt and Training
 ;;^UTILITY(U,$J,358.3,12208,1,3,0)
 ;;=3^97760
 ;;^UTILITY(U,$J,358.3,12209,0)
 ;;=97761^^67^739^3^^^^1
 ;;^UTILITY(U,$J,358.3,12209,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12209,1,2,0)
 ;;=2^Prosthetic Training
 ;;^UTILITY(U,$J,358.3,12209,1,3,0)
 ;;=3^97761
 ;;^UTILITY(U,$J,358.3,12210,0)
 ;;=97001^^67^740^4^^^^1
 ;;^UTILITY(U,$J,358.3,12210,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12210,1,2,0)
 ;;=2^PT Evaluation
 ;;^UTILITY(U,$J,358.3,12210,1,3,0)
 ;;=3^97001
 ;;^UTILITY(U,$J,358.3,12211,0)
 ;;=97002^^67^740^5^^^^1
 ;;^UTILITY(U,$J,358.3,12211,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12211,1,2,0)
 ;;=2^PT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,12211,1,3,0)
 ;;=3^97002
 ;;^UTILITY(U,$J,358.3,12212,0)
 ;;=97003^^67^740^1^^^^1
 ;;^UTILITY(U,$J,358.3,12212,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12212,1,2,0)
 ;;=2^OT Evaluation
 ;;^UTILITY(U,$J,358.3,12212,1,3,0)
 ;;=3^97003
 ;;^UTILITY(U,$J,358.3,12213,0)
 ;;=97004^^67^740^2^^^^1
 ;;^UTILITY(U,$J,358.3,12213,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12213,1,2,0)
 ;;=2^OT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,12213,1,3,0)
 ;;=3^97004
 ;;^UTILITY(U,$J,358.3,12214,0)
 ;;=97750^^67^740^3^^^^1
 ;;^UTILITY(U,$J,358.3,12214,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12214,1,2,0)
 ;;=2^Physical Performance Test (KT Eval)
 ;;^UTILITY(U,$J,358.3,12214,1,3,0)
 ;;=3^97750
 ;;^UTILITY(U,$J,358.3,12215,0)
 ;;=G0151^^67^741^5^^^^1
 ;;^UTILITY(U,$J,358.3,12215,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12215,1,2,0)
 ;;=2^PT in home/hospice,ea 15min
